These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 6115052

  • 1. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
    Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA.
    J Pharmacol Exp Ther; 1981 Sep; 218(3):739-49. PubMed ID: 6115052
    [No Abstract] [Full Text] [Related]

  • 2. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
    Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L.
    J Cyclic Nucleotide Res; 1979 Sep; 5(3):211-24. PubMed ID: 39089
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.
    Katsuki S, Arnold W, Mittal C, Murad F.
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978
    [Abstract] [Full Text] [Related]

  • 4. Vascular nitric oxide-generating activities for organic nitrites and organic nitrates are distinct.
    Kowaluk EA, Fung HL.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):519-25. PubMed ID: 1682477
    [Abstract] [Full Text] [Related]

  • 5. Possible mechanisms of activation of soluble guanylate cyclase by organic nitrates.
    Yeates RA.
    Arzneimittelforschung; 1992 Nov; 42(11):1314-7. PubMed ID: 1362874
    [Abstract] [Full Text] [Related]

  • 6. Cellular mechanisms of nitrate action.
    Fung HL, Chung SJ, Chong S, Hough K, Kakami M, Kowaluk E.
    Z Kardiol; 1989 Nov; 78 Suppl 2():14-7; discussion 64-7. PubMed ID: 2573980
    [Abstract] [Full Text] [Related]

  • 7. Methemoglobin blockade of coronary arterial soluble guanylate cyclase activation by nitroso compounds and its reversal with dithiothreitol.
    Ohlstein EH, Barry BK, Gruetter DY, Ignarro LJ.
    FEBS Lett; 1979 Jun 15; 102(2):316-20. PubMed ID: 37124
    [No Abstract] [Full Text] [Related]

  • 8. Nitrite ion is not an active intermediate in the vascular metabolism of organic nitrates and organic nitrites to nitric oxide.
    Kowaluk EA, Chung SJ, Fung HL.
    Drug Metab Dispos; 1993 Jun 15; 21(5):967-9. PubMed ID: 7902265
    [No Abstract] [Full Text] [Related]

  • 9. Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside.
    Lewicki JA, Brandwein HJ, Mittal CK, Arnold WP, Murad F.
    J Cyclic Nucleotide Res; 1982 Jun 15; 8(1):17-25. PubMed ID: 6127356
    [Abstract] [Full Text] [Related]

  • 10. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.
    Craven PA, DeRubertis FR.
    J Biol Chem; 1978 Dec 10; 253(23):8433-43. PubMed ID: 30778
    [Abstract] [Full Text] [Related]

  • 11. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.
    Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ.
    J Pharmacol Exp Ther; 1981 Oct 10; 219(1):181-6. PubMed ID: 6270297
    [Abstract] [Full Text] [Related]

  • 12. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
    Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1984 Jan 10; 228(1):33-42. PubMed ID: 6319670
    [Abstract] [Full Text] [Related]

  • 13. Prolonged exposure of canine coronary arteries to a nitric oxide donor desensitizes soluble guanylate cyclase.
    Sorajja P, Cable DG, Hamner CE, Schaff HV.
    J Surg Res; 2005 Jan 10; 123(1):82-8. PubMed ID: 15652954
    [Abstract] [Full Text] [Related]

  • 14. Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide.
    Gruetter CA, Barry BK, McNamara DB, Kadowitz PJ, Ignarro LJ.
    J Pharmacol Exp Ther; 1980 Jul 10; 214(1):9-15. PubMed ID: 6104719
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.
    Feelisch M, Noack EA.
    Eur J Pharmacol; 1987 Jul 02; 139(1):19-30. PubMed ID: 2888663
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine--inhibition by calcium, lanthanum, and other cations, enhancement by thiols.
    Gruetter DY, Gruetter CA, Barry BK, Baricos WH, Hyman AL, Kadowitz PJ, Ignarro LJ.
    Biochem Pharmacol; 1980 Nov 01; 29(21):2943-50. PubMed ID: 6109533
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.